about
Reprofiled drug targets ancient protozoans: drug discovery for parasitic diarrheal diseasesUse of bacterially expressed dsRNA to downregulate Entamoeba histolytica gene expressionHuman milk oligosaccharides: every baby needs a sugar mamaThe impact of the gut microbiota on human health: an integrative viewLeptin and mucosal immunity.A novel class of cysteine protease receptors that mediate lysosomal transport.Tissue destruction and invasion by Entamoeba histolytica.Entamoeba histolytica infection and secreted proteins proteolytically damage enteric neuronsAntiamoebic properties of the actinomycete metabolites echinomycin A and tirandamycin AThe role of lipopeptidophosphoglycan in the immune response to Entamoeba histolytica.Entamoeba histolytica Infection in Female Sex Workers: A Matched Case-Control Study in Durango, Mexico.Importance of innate mucosal immunity and the promises it holds.Novelties on amoebiasis: a neglected tropical disease.Microbial eukaryotes in the human microbiome: ecology, evolution, and future directions.RNAi pathway genes are resistant to small RNA mediated gene silencing in the protozoan parasite Entamoeba histolyticaStructure of an ADP-ribosylation factor, ARF1, from Entamoeba histolytica bound to Mg(2+)-GDP.Branch portal vein pyaemia secondary to amoebic liver abscess.Clinical manifestations and endoscopic findings of amebic colitis in a United States-Mexico border city: a case series.Enteric protozoa in the developed world: a public health perspective.Molecular Epidemiology of Entamoeba: First Description of Entamoeba moshkovskii in a Rural Area from Central Colombia.Development of RNA Interference Trigger-Mediated Gene Silencing in Entamoeba invadens.Structure-function relationships of human milk oligosaccharides.Amebic Liver Abscess in Israeli Travelers: A Retrospective StudyPREVALENCE, RISK FACTORS AND SYMPTOMS ASSOCIATED TO INTESTINAL PARASITE INFECTIONS AMONG PATIENTS WITH GASTROINTESTINAL DISORDERS IN NAHAVAND, WESTERN IRANMolecular testing for clinical diagnosis and epidemiological investigations of intestinal parasitic infections.Atypical ulcers.Diagnostic errors of right lower quadrant pain in children: beyond appendicitis.Colocutaneous fistula secondary to amoebiasis.Synthesis, characterization, and anti-amoebic activity of N-(pyrimidin-2-yl)benzenesulfonamide derivatives.Amoebic liver abscess with negative serologic markers for Entamoeba histolytica: mind the gap!Human milk oligosaccharide composition differs between donor milk and mother's own milk in the NICU.Molecular prevalence of Entamoeba histolytica/dispar infection among patients attending four health centres in north-west Ethiopia.A Unique Case of Empyema Secondary to Amoebic Liver Abscess.Primary Pulmonary Amebiasis Complicated with Multicystic Empyema.Burden of major diarrheagenic protozoan parasitic co-infection among amoebic dysentery cases from North East India: a case report.Genomic diversity of the human intestinal parasite Entamoeba histolytica.Evaluation of the BD Max Enteric Parasite Panel for Clinical DiagnosticsRelapse of intestinal and hepatic amebiasis after treatment.Laboratory Diagnosis of Parasites from the Gastrointestinal Tract.Human milk oligosaccharides reduce Entamoeba histolytica attachment and cytotoxicity in vitro.
P2860
Q27003233-87EF413E-1362-4F13-B661-4383E588A439Q28472305-C8EA58BA-DF99-41D7-BACE-FB1FE8F3DA6FQ28728728-D132589C-5B24-4D42-A076-4A0BD151F94FQ29617446-E687B5E0-184C-4046-B94F-217DE4829288Q30422264-A0016C83-0FC1-48D6-841E-FD1F6C2060C3Q30424581-2136B044-0EDC-4940-9E0E-B8AAC7FC9CA9Q30426761-32E64AB2-5C1B-4F0E-ADD2-7ACCC3D1396EQ30432112-C50EB1C9-6C42-48CD-A590-973FE504FA03Q30528009-080B7D38-05CD-4159-9BD3-D341B8792791Q33633292-7DDB6385-183C-4BFD-8396-C48261838E20Q33763334-87844814-A605-490D-A69D-9C099CEA5618Q34894817-413BD701-BD41-4986-AE5A-076C0317572AQ35073458-B6DBEB3B-C14D-4529-9AB6-8E82FE7A4E16Q35103951-5356AB81-9772-4215-8B23-868F6D4A9B5BQ35242243-FA1066F3-AEA6-435A-9CA4-719B1DB6DD25Q35592558-509E1E21-1090-4411-8E02-30E03E8831E7Q35698652-9C2795DC-0814-418A-82CF-67AC43E80FDDQ35868509-BC316975-DE21-4225-9482-7B727569BCBEQ36156094-1564A1A9-4FDB-43F8-B811-29F03810B5F6Q36161722-C86231E4-E6CD-4941-A15F-1427BE0197D3Q36727993-8D86F39C-AA53-41EC-868B-1C0C478BCD63Q36830433-D22C862C-4AEB-4775-AF41-6313E3036B49Q36869498-27DF1CBC-45A5-479B-B8A1-F6793D74BCF5Q36935032-EBE8F86A-36E4-4E54-9AF1-380E860DD7F7Q37712806-2AADEBD7-A060-4363-9DED-53353ACE5B18Q38112476-91CAD758-4EF1-4AF4-9A01-240B586DE21AQ38542203-47A8A145-D65C-4725-BB9C-81D2C100AB38Q38798173-012C17F2-2E01-44A0-8DED-1A60B942A2B0Q39044582-BBB29CC2-F323-4D89-93A1-2189737C5560Q39216413-D4E7C1A1-1691-46F2-8155-3DF97A2BE27FQ39306466-4E009E1D-8840-43F5-9D11-986AE8E294E8Q39616260-93D4DE57-D010-458B-B889-B57D9E560672Q40044644-20E2B390-7D03-49E7-9400-64F95EB5E623Q40593297-79B95FCC-6059-4542-8CD7-935DE1A55221Q41146265-0E5AE305-C3C2-498A-8EC3-2E744E3EFB73Q42326257-4237F5E9-9C90-4570-B475-E5A9BA536502Q42537092-4CFC4EB3-A918-4EDE-9FAC-805ABA1611ADQ43696094-53CC4BBA-738F-4868-8792-35CB41EB3F7DQ45954477-BB24285D-BC5F-4BD6-B69F-AB00BD626EA9Q46206396-01EF3405-74E0-494D-8AE1-E30FC6482B58
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Amebiasis.
@ast
Amebiasis.
@en
Amebiasis.
@nl
type
label
Amebiasis.
@ast
Amebiasis.
@en
Amebiasis.
@nl
prefLabel
Amebiasis.
@ast
Amebiasis.
@en
Amebiasis.
@nl
P356
P1476
Amebiasis.
@en
P304
1154-9; quiz 1159-60
P356
10.4065/83.10.1154
P407
P577
2008-10-01T00:00:00Z